| Frances Harmon, RN | |
|
1802 6th Ave S, Birmingham, AL 35233-1932 | |
| (256) 783-7659 | |
| Not Available |
| Full Name | Frances Harmon |
|---|---|
| Gender | Female |
| Speciality | Registered Nurse - Neuroscience |
| Location | 1802 6th Ave S, Birmingham, Alabama |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1033739065 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 163WN0800X | Registered Nurse - Neuroscience | 1-171421 (Alabama) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Frances Harmon, RN 1802 6th Ave S, Birmingham, AL 35233-1932 Ph: (256) 783-7659 | Frances Harmon, RN 1802 6th Ave S, Birmingham, AL 35233-1932 Ph: (256) 783-7659 |
News Archive
Cord Blood Registry, the world's largest and most experienced newborn stem cell company, announces the start of a U.S. Food and Drug-regulated study being conducted at Florida Hospital for Children in Orlando to investigate the use of a child's stem cells from their own stored umbilical cord blood as a treatment for acquired sensorineural hearing loss.
The Institute for Translational Medicine and Therapeutics' 7th Annual International Symposium (ITMAT) symposium, Harnessing the Paradox: Personalization and the Science of Scale, to be held in October 2013, will address topics of direct relevance to translational science.
A new study reveals that samples of sputum and feces continue to test positive for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus even after a person has recovered from COVID-19 and nasopharyngeal secretions test negative for the virus.
Rather than work with us to find a true compromise, members who support abortion rights ignored our concerns (Rep. Bart Stupak, D-Mich., 11/18).
Baxter International Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved GAMMAGARD LIQUID 10% [Immune Globulin Infusion (Human)] as a treatment for multifocal motor neuropathy (MMN). This is the first immunoglobulin treatment approved for MMN patients in the United States, and it was approved for use with MMN patients in Europe in 2011.
› Verified 1 days ago
Madison Thomas Hulker, WHNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 1700 6th Ave S, Birmingham, AL 35233 Phone: 205-934-3411 | |
Shannon Marie Harrison, BSN, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 619 19th St S, Birmingham, AL 35233 Phone: 205-934-6050 | |
Mrs. Leah York Richardson, Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 619 19th St S, Birmingham, AL 35249 Phone: 205-242-8734 | |
Tyler Bishop, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 1802 6th Ave S, Birmingham, AL 35233 Phone: 256-490-6381 | |
Emily Karanja, CRNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 50 Medical Park Dr E, Birmingham, AL 35235 Phone: 205-838-3245 | |
Emily Jane Bloom, NP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 3419 Colonnade Pkwy Ste 600, Birmingham, AL 35243 Phone: 205-598-6800 Fax: 205-598-6700 | |
Latasha Davis, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 615 18th St S, Birmingham, AL 35233 Phone: 205-996-3050 |